Symrise’s SymWhite 377 [1] will now be authorised for used in cosmetic products marketed in China as the supplier of fragrance and cosmetic active ingredients successfully completed the registration process with the Chinese State Food and Drug Administration (SFDA).
Considering the importance of the skin whiteners in Asia, which consumers use to remove age-linked stains or to get a clear and even complexion, effective and safe lightening ingredients have a huge potential in China.
“SymWhite 377 has an excellent safety profile and provides visible effects in less than 14 days. SymWhite 377 can improve the appearance of dull complexions, can promote clarity and brightness, and provide a beautiful, uniform skin tone. Further, it can also diminish the appearance of dark facial hair. As a powerful anti-oxidant it delivers an added functional value,” Symrise claims.
SymWhite 377 is inspired from pinosylvin, a natural skin brightening compound occurring in pine. It was synthesized and screened for tyrosinase inhibitory activity as well as for antioxidant efficacy. Its efficacy has been tested in vitro, in vivo and ex vivo. A clinical study with Asian subjects showed that 0.5% SymWhite 377 is a more effective solution for brighter skin than 1.0 % kojic acid.
“We wanted to create a product that incorporates various advantages,” explains Dr. Gabriele Vielhaber, Senior Vice President Global Business Unit Cosmetic Ingredients at Symrise. “SymWhite 377 combines innovation with product safety and market insights. That is why we are really pleased that the SFDA has approved our active component in China. Our customers that are active on the Asian market can now develop effective products that fulfill the wish for an even and radiant skin and that give care and protection at the same time.”
